✦ LIBER ✦

Is continued enthusiasm for ursodeoxycholic acid therapy for the treatment of primary biliary cirrhosis warranted?

✍ Scribed by Russell H. Wiesner

Publisher: John Wiley and Sons
Year: 1992
Tongue: English
Weight: 438 KB
Volume: 15
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.1840150536

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Is the Mayo model for predicting surviva

Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis?

✍ M R Kilmurry; E J Heathcote; K Cauch-Dudek; K O'Rourke; R J Bailey; L M Blendis; 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 1 views

Treatment of patients with primary biliary cirrhosis eral prognostic indicators have been proposed and (PBC) using ursodeoxycholic acid (UDCA) leads to a reprognostic indexes developed to predict survival. duction in serum bilirubin. The first objective of this Shapiro et al. 1 showed that serum bi

Long-term survival and impact of ursodeo

Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation

✍ Phunchai Charatcharoenwitthaya; Sylvania Pimentel; Jayant A. Talwalkar; Felicity 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 275 KB 👁 1 views

The recurrence of primary biliary cirrhosis (PBC) in the hepatic allograft may impact patient and graft survival with long-term follow-up. The efficacy of ursodeoxycholic acid (UDCA) for treatment of recurrent PBC after liver transplantation (LT) remains less well known. The aims of this study were